Transcriptional regulation of the COX-2 expression by nitric oxide in colon cancer cell lines

被引:0
|
作者
Liu, Qiang [1 ]
Inoue, Hiroyasu [2 ]
Mahendran, Ratha [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119260, Singapore
[2] Nara Womens Univ, Dept Food Sci & Nutr, Nara 630, Japan
关键词
nitric oxide; cyclooxygenase-2; CRE and NF-IL6 transcription factor binding sites;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine the effect of nitric oxide (NO) on the cyclooxygenase-2 (COX-2) regulation in colon cancer cell lines we used the physiological NO donor GSNO. The proximal 6.6 kb of the COX-2 promoter was cloned into the pGL3 basic vector and the sequential deletion of the 6.6 kb COX-2 promoter generated promoter constructs of 4, 2.6, 1.9 and 0.9 kb. These constructs clearly show that the main regulatory region lies within 0.9 kb of the transcription start site. Therefore, constructs of the main transcription binding sites within this region namely CRE, NF-IL6 and NF-kappa B and mutations of these sites were used to monitor the transcriptional activation of COX-2. This study was performed on the colon cancer cell lines HCA7 and HCT 116 which have a differential expression of COX-2. There was no evidence that the luciferase activity is negatively affected by NO as was previously reported. The CRE and NF-IL6 binding sites within this region were responsible for the constitutive and physiological NO-induced COX-2 transcriptional activity in the HCA7 and HCT 116 cells. While NF-kappa B involvement was only observed in the HCT116 cells, the cell lines displayed increased NF-kappa B transcriptional activity after exposure to NO.
引用
收藏
页码:269 / 274
页数:6
相关论文
共 50 条
  • [31] Bidirectional Regulation of COX-2 Expression Between Cancer Cells and Macrophages
    Carvalho, Maria Isabel
    Bianchini, Rodolfo
    Fazekas-Singer, Judit
    Herrmann, Ina
    Flickinger, Irene
    Thalhammer, Johann G.
    Pires, Isabel
    Jensen-Jarolim, Erika
    Queiroga, Felisbina L.
    ANTICANCER RESEARCH, 2018, 38 (05) : 2811 - 2817
  • [32] Enhanced COX-2 expression in the colon following radiotherapy
    Gupta, J
    Moorghen, M
    Halton, DE
    Baker, J
    Paraskeva, C
    Elder, DJE
    JOURNAL OF PATHOLOGY, 2001, 193 : 26A - 26A
  • [33] Regulation of COX-2 expression in canine prostate carcinoma: Increased COX-2 expression is not related to inflammation
    L'Eplattenier, Henry F.
    Lai, Chen Li
    van den Ham, Rene
    Mol, Jan
    van Sluijs, Frederick
    Teske, Erik
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, 21 (04): : 776 - 782
  • [34] COX-2 expression in benign serrated polyps of the colon
    Kiedrowski, M.
    Mroz, A.
    Orlowska, J.
    Kraszewska, E.
    Rembiszewska, A.
    Felisiak-Golabek, A.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 205 - 205
  • [35] COX-2 Expression in Gastric Cancer
    Bekdemir, Handan
    Tekin, Salim B.
    Bilici, Mehmet
    Cayir, Kerim
    Gundogdu, Cemal
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2010, 20 (01): : 34 - 41
  • [36] Regulation of COX-2 expression in human cancers
    Dixon, DA
    COX-2: A NEW TARGET FOR CANCER PREVENTION AND TREATMENT, 2003, 37 : 52 - 71
  • [37] Regulation of COX-2 transcription in a colon cancer cell line by Pontin52/TIP49a
    Mary L Carlson
    Ellen T Wilson
    Stephen M Prescott
    Molecular Cancer, 2 (1)
  • [38] COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib
    Grösch, S
    Tegeder, I
    Niederberger, E
    Bräutigam, L
    Geisslinger, G
    FASEB JOURNAL, 2001, 15 (12): : 2742 - +
  • [39] Cyclooxygenase-2 (COX-2) expression in uveal melanoma and macrophage cell lines
    Pardo, M
    Marshall, JCA
    Caissie, AL
    Callejo, SA
    Burnier, MN
    Pinard, G
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U248 - U248
  • [40] Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53
    Swamy, MV
    Herzog, CR
    Rao, CV
    CANCER RESEARCH, 2003, 63 (17) : 5239 - 5242